Abstract
The human prion diseases are a diverse group of neurodegenerative diseases that are classified by several criteria including disease etiology, PRNP polymorphisms at codon 129, PrPSc types and subtypes, prion incubation period and disease duration, clinical presentation and neuropathology. Creutzfeldt-Jakob disease (CJD) is unique in that it can have a sporadic, inherited, and infectious etiology, and all three forms can subsequently be transmitted following experimental inoculation of brain tissue. PrPSc is an unusual pathogen that fails to induce a prion-specific host immune response, but PrPSc-induced damage to the brain likely causes a proinflammatory response that contributes to neurodegeneration. The human prion diseases are primarily localized to the nervous system, but variant CJD (vCJD) also has a peripheral distribution in secondary lymphoid tissues that is consistent with oral exposure to bovine spongiform encephalopathy (BSE). The prion agent uses the immune system for targeting to lymphoid organs, agent replication, and neuroinvasion through fibers that innervate lymphoid tissues. In chronic inflammatory conditions in which lymphoid organogenesis can occur in non-lymphoid tissues, ectopic peripheral prion infection can be established and could play a role in prion transmission.
We are very saddened that Dr. Richard Bessen passed away recently. Richard is a well-known scientist in the prion field. He has made significant contributions to many aspects of prions and prion diseases, including the etiology, strains, transmission, shedding and neuroinvasion of various prions. He will be missed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguzzi A, Heikenwalder M (2005) Prions, cytokines, and chemokines: a meeting in lymphoid organs. Immunity 22:145–154
Alpers M (1979) Epidemiology and ecology of kuru. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system. Academic, New York, pp 67–92
Arantes C, Nomizo R, Lopes MH, Hajj GN, Lima FR, Martins VR (2009) Prion protein and its ligand stress inducible protein 1 regulate astrocyte development. Glia 57:1439–1449
Beekes M, McBride PA, Baldauf E (1998) Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J Gen Virol 79:601–607
Bribián A, Fontana X, Llorens F, Gavín R, Reina M, García-Verdugo JM, Torres JM, de Castro F, del Río JA (2012) Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS. PLoS One 7, e33872
Brown P (2013) Environmentally acquired transmissible spongiform encephalopathy. In: Zou WQ, Gambetti P (eds) Prions and diseases: vol 2, Animals, humans, and the environment. Springer Science + Business Media, New York, pp 73–88
Burwinkel M, Riemer C, Schwarz A, Schultz J, Neidhold S, Bamme T, Baier M (2004) Role of cytokines and chemokines in prion infections of the central nervous system. Int J Dev Neurosci 22:497–505
Clavaguera F, Bolmont T, Crowther A, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–914
Clewley JP, Kelly CM, Andrews N, Vogliqi K, Mallinson G, Kaisar M, Hilton DA, Ironside JW, Edwards P, McCardle LM, Ritchie DL, Dabaghian R, Ambrose HE, Gill ON (2009) Prevalence of disease related prion protein in anonymous tonsil specimes in Britain: cross sectional opportunistic survey. Br Med J 338:b1442
Collinge J, Whitfield J, McKintosh E, Frosh A, Mead S, Hill AF, Brandner S, Thomas D, Alpers MP (2008) A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos Trans R Soc Lond B Biol Sci 363:3725–3739
Cooper JD, Bird SM (2003) Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts. Int J Epidemiol 32:784–791
Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 104:9741–9746
Eklund CM, Hadlow WJ (1969) Pathogenesis of slow viral diseases. J Am Vet Med Assoc 155:2094–2099
Gajdusek DC, Gibbs CJJ, Alpers M (1966) Experimental transmission of a kuru-like syndrome in chimpanzees. Nature 209:794–796
Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi P (1995) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 5:43–51
Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterization. Br Med Bull 66:213–239
Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, Montine T, Wisniewski T, Dickson DW, Soto C, Hulette CM, Mastrianni JA, Kong Q, Zou WQ (2008) A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 63:697–708
Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, Tagliavini F (1995) Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol 5:61–75
Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L, Linehan J, Simmons M, Webb P, Bellerby P, Andrews N, Hilton DA, Ironside JW, Beck J, Poulter M, Mead S, Brandner S (2013) Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347:f5675
Glatzel M, Heppner FL, Albers KM, Aguzzi A (2001) Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31:25–34
Glatzel M, Abela E, Maissen M, Aguzzi A (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349:1812–1820
Guerreiro R, Brás J, Wojtas A, Rademakers R, Hardy J, Graff-Radford N (2014) A nonsense mutation in PRNP associated with clinical Alzheimer’s disease. Neurobiol Aging 35:2656e.13–2656e.16
Hadlow WJ (1959) Scrapie and kuru. Lancet 2:289–290
Hartmann CA, Martins VR (2013) Lima FR (2013) High levels of cellular prion protein improve astrocyte development. FEBS Lett 587(2):238–244
Head MW, Ritchie D, Smith N, McLoughlin V, Nailon W, Samad S, Masson S, Bishop M, McCardle L, Ironside JW (2004) Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 164:143–153
Head MW, Yull HM, Ritchie DL, Langeveld JP, Fletcher NA, Knight RS, Ironside JW (2013) Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008. Brain 136:1102–1115
Heggebo R, Press CM, Gunnes G, Lie KI, Tranulis MA, Ulvund M, Groschup MH, Landsverk T (2000) Distribution of prion protein in the ileal Peyer’s patch of scrapie-free lambs and lambs naturally and experimentally exposed to the scrapie agent. J Gen Virol 81(Pt 9):2327–2337
Heikenwalder M, Zeller N, Seeger H, Prinz M, Klohn PC, Schwarz P, Ruddle NH, Weissmann C, Aguzzi A (2005) Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307:1107–1110
Hilton DA (2006) Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J Pathol 208:134–141
Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203:733–739
Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590
Ironside JW (2006) Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies. Haemophilia Suppl 1:8–15
Ironside JW, Ritchie DL, Head MW (2005) Phenotypic variability in human prion diseases. Neuropathol Appl Neurobiol 31:565–579
Ishida C, Okino S, Kitamoto T, Yamada M (2005) Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 76:325–329
Jarrett JT, Lansbury PT Jr (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73:1055–1058
Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, Surewicz WK (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285:14083–14087
Kimberlin RH, Walker CA (1989) The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res 12:201–211
Kong Q, Surewicz WK, Petersen RB, Zou W, Chen SG, Gambetti P, Parchi S, Capellari L, Goldfarb P, Montagna E, Lugaresi P, Piccardo P, Ghetti B (2003) Inherited prion diseases. In: Prusiner SB (ed) Prion biology and diseases, 2nd edn. Cold Spring Harbor Laboratory Press, New York, pp 673–776
Konold T, Moorse SJ, Bellworthy SJ, Simmons HA (2008) Evidence of scrapie transmission via milk. BMC Vet Res 4:14
Kovacs GG, Gasque P, Strobel T, Lindeck-Pozza E, Strohschneider M, Ironside JW, Budka H, Guentchev M (2004) Complement activation in human prion disease. Neurobiol Dis 15:21–28
Lacroux C, Simon S, Benestad SL, Maillet S, Mathey J, Lugan S, Corbiere F, Cassard H, Costes P, Bergonier D, Weisbecker J-L, Moldal T, Simmons H, Lantier F, Feraudet-Tarisse C, Morel N, Schelcher F, Grassi J, Andreoletti O (2008) Prions in milk from ewes incubating natural scrapie. PLoS Pathog 4, e1000238
Lasmezas CI (2003) Putative functions of PrP(C). Br Med Bull 66:61–70
Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB (2004) Synthetic mammalian prions. Science 305:673–676
Ligios C, Sigurdson CJ, Santucciu C, Carcassola G, Manco G, Basagni M, Maestrale C, Cancedda MG, Madau L, Aguzzi A (2005) PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat Med 11:1137–1138
Ma J, Wang F (2014) Prion disease and the ‘protein-only hypothesis’. Essays Biochem 56:181–191
Mabbott N, Turner M (2005) Prions and the blood and immune systems. Haematologica 90:542–548
Mabbott NA (2004) The complement system in prion diseases. Curr Opin Immunol 16:587–593
Maheshwari A, Fischer M, Gambetti P, Parker A, Ram A, Soto C, Concha-Marambio L, Cohen Y, Belay ED, Maddox RA, Mead S, Goodman C, Kass JS, Schonberger LB, Hussein HM (2015) Recent us case of variant creutzfeldt-jakob disease-global implications. Emerg Infect Dis 21:750–759
Makrinou E, Collinge J, Antoniou M (2002) Genomic characterization of the human prion protein (PrP) gene locus. Mamm Genome 13:696–703
McBride PA, Schulz-Schaeffer WJ, Donaldson M, Bruce ME, Diringer H, Kretzschmar HA, Beekes M (2001) Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J Virol 75:9320–9327
Mead S, Gandhi S, Beck J, Caine D, Gajulapalli D, Carswell C, Hyare H, Joiner S, Ayling H, Lashley T, Linehan JM, Al-Doujaily H, Sharps B, Revesz T, Sandberg MK, Reilly MM, Koltzenburg M, Forbes A, Rudge P, Brandner S, Warren JD, Wadsworth JD, Wood NW, Holton JL, Collinge J (2013) A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med 369:1904–1914
Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret J-M, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313:1781–1784
Mikol J (1999) Neuropathology of prion diseases. Biomed Pharmacother 53:19–26
Mitchell DA, Kirby L, Paulin SM, Villiers CL, Sim RB (2007) Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scapie agent propagation in lymphoid tissue. Mol Immunol 44:2997–3004
Moda F, Gambetti P, Notari S, Concha-Marambio L, Catania M, Park W-K, Maderna E, Suardi S, Haik S, Brandel J-P, Ironside J, Knight R, Tagliavini F, Soto C (2014) Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med 371:530–539
Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2:167–176
Nieznanski K, Podlubnaya ZA, Nieznanska H (2006) Prion protein inhibits microtubule assembly by inducing tubulin oligomerization. Biochem Biophys Res Commun 349:391–399
Nieznanska H, Dudek E, Zajkowski T, Szczesna E, Kasprzak AA, Nieznanski K (2012) Prion protein impairs kinesin-driven transport. Biochem Biophys Res Commun 425:788–793
Notari S, Moleres FJ, Hunter SB, Belay ED, Schonberger LB, Cali I, Parchi P, Shieh W-J, Brown P, Zaki S, Zou W-Q, Gambettei P (2010) Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One 5, e8765
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects [In Process Citation]. Ann Neurol 46:224–233
Peden AH, Ritchie DL, Head MW, Ironside JW (2006) Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168:927–935
Peralta OA, Huckle WR, Eyestone WH (2011) Expression and knockdown of cellular prion protein (PrPC) in differentiating mouse embryonic stem cells. Differentiation 81:68–77
Prinz M, Heikenwalder M, Junt T, Schwarz P, Glatzel M, Heppner FL, Fu YX, Lipp M, Aguzzi A (2003) Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425:957–962
Prodromidou K, Papastefanaki F, Sklaviadis T, Matsas R (2014) Functional cross-talk between the cellular prion protein and the neural cell adhesion molecule is critical for neuronal differentiation of neural stem/precursor cells. Stem Cells 32:1674–1687
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
Prusiner SB (1991) Molecular biology of prion diseases. Science 252:1515–1522
Prusiner SB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47:601–623
Rubenstein R, Chang B (2013) Re-assessment of PrPSc distribution in sporadic and variant CJD. PLoS One 8, e66352
Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, Riesner D (2005) Search for a prion-specific nucleic acid. J Virol 79:10796–10806
Sailer A, Bueler H, Fischer M, Aguzzi A, Weissmann C (1994) No propagation of prions in mice devoid of PrP. Cell 77:967–968
Santos TG, Silva IR, Costa-Silva B, Lepique AP, Martins VR, Lopes MH (2011) Enhanced neural progenitor/stem cells self-renewal via the interaction of stress-inducible protein 1 with the prion protein. Stem Cells 29:1126–1136
Seeger H, Heikenwalder M, Zeller N, Kranich J, Schwarz P, Gaspert A, Seifert B, Miele G, Aguzzi A (2005) Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310:324–326
Singh A, Haldar S, Horback K, Tom C, Zhou L, Meyerson H, Singh N (2013) Prion protein regulates iron transport by functioning as a ferrireductase. J Alzheimers Dis 35:541–552
Solis GP, Radon Y, Sempou E, Jechow K, Stuermer CA, Málaga-Trillo E (2013) Conserved roles of the prion protein domains on subcellular localization and cell-cell adhesion. PLoS One 8, e70327
Steele AD, Emsley JG, Ozdinler PH, Lindquist S, Macklis JD (2006) Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci U S A 103:3416–3421
Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, Moser M, Oesch B, McBride PA, Manson JC (1996) Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380:639–642
van Keulen LJ, Schreuder BE, Vromans ME, Langeveld JP, Smits MA (1999) Scrapie-associated prion protein in the gastrointestinal tract of sheep with natural scrapie. J Comp Pathol 121:55–63
van Keulen LJ, Schreuder BE, Vromans ME, Langeveld JP, Smits MA (2000) Pathogenesis of natural scrapie in sheep. Arch Virol Suppl 16:57–71
Wang F, Wang X, Yuan CG, Ma J (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132–1135
Will RG (2003) Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 66:255–265
Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–925
Wong BS, Chen SG, Colucci M, Xie Z, Pan T, Liu T, Li R, Gambetti P, Sy MS, Brown DR (2001) Aberrant metal binding by prion protein in human prion disease. J Neurochem 78:1400–1408
Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, Head MW (2006) Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 168:151–157
Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, Kranich J, von Teichman A, Haas KM, Zeller N, Tedder TF, Weis JH, Aguzzi A (2007) Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J Immunol 179:6144–6152
Zeidler M, Sellar RJ, Collie DA, Knight R, Stewart G, Macleod MA, Ironside JW, Cousens S, Colchester AC, Hadley DM, Will RG (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355:1412–1418
Zhang CC, Steele AD, Lindquist S, Lodish HF (2006) Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci U S A 103:2184–2189
Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 278:40429–40436
Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, Shimoji M, Langeveld JP, Castellani R, Notari S, Crain B, Schmidt RE, Geschwind M, Dearmond SJ, Cairns NJ, Dickson D, Honig L, Torres JM, Mastrianni J, Capellari S, Giaccone G, Belay ED, Schonberger LB, Cohen M, Perry G, Kong Q, Parchi P, Tagliavini F, Gambetti P (2010) Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 68:162–172
Zou WQ, Gambetti P, Xiao X, Yuan J, Langeveld J, Pirisinu L (2013) Prions in variably protease-sensitive prionopathy: an update. Pathogens 2:457–471
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kong, Q., Bessen, R.A. (2017). Prion Diseases. In: Ikezu, T., Gendelman, H. (eds) Neuroimmune Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-44022-4_34
Download citation
DOI: https://doi.org/10.1007/978-3-319-44022-4_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44020-0
Online ISBN: 978-3-319-44022-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)